Alison Buttenheim of the School of Nursing spoke about public perceptions of different COVID-19 vaccines. “I worried that we’re going to have that kind of consumer-driven ‘Oh, is it Moderna? Great! Is it [Johnson & Johnson]? No, thank you, I’ll wait,’” she said. “That’s just going to delay getting to the coverage that we want to get to.”